Fischer Medical Ventures cash flow

Latest FY26
Cash from operations
−₹101cr 
Capital spending
₹1.3cr 
Free cash flow
−₹103cr 
Cash from financing
₹14.1cr 
₹ crore except per share
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026
Adjustments to reconcile profit — non-cash items
—3.0
—2.6
—9.0
—−1.2
Changes in working capital
—−3.5
—−216
—0.8
—−13.3
—−59.9
—3.3
—81.9
—0.7
—1.7
—60.0
—0.4
Cash from operating activities
44.146.6
—−130
—−83.6
—17.7
—−101
Cash from investing activities
—1.3
—27.2
—114
—1.3
—139
—−5.2
Cash from financing activities
—13.1
—7.6
—3.8
—2.6
—0.3
—14.1
—−92.4
—−92.4
Reference items
50.143.1
13.6%14.0%
−103−103
−₹1.57−₹1.57
—−3.26×
—17.7
—2.6
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

FISCHER₹25.93

Fischer Medical Ventures Limited

· Pharma & Health
₹ CrorePeersTARSONSLAXMIDENTLFABTECHGKBMcap ₹1,697 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation3.0—
+ Finance Costs2.6—
+ Other Non-cash Items9.0—
+ Other Reconciling Items-1.2—
Changes in Working Capital
+ Inventories-3.5—
+ Trade Receivables — Current-215.8—
+ Other Financial Assets — Current0.8—
+ Other Financial Assets — Non-current-13.3—
+ Other Current Assets-59.9—
+ Other Non-current Assets3.3—
+ Trade Payables — Current81.9—
+ Other Financial Liabilities — Current0.7—
+ Other Current Liabilities1.7—
+ Provisions — Current60.0—
+ Provisions — Non-current0.4—
Cash from Operating Activities
Profit Before Tax (per I/S)46.644.1
+ Total Adjustments (incl. Working Capital)-130.2—
Cash from Operations (pre-tax)-83.6—
+ Income Taxes Paid17.7—
Cash from Operating Activities-101.3—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)1.3—
+ Purchase of Investments (Equity / Debt)27.2—
+ Acq of Subsidiaries / Businesses (net)114.2—
+ Loans & Advances Made1.3—
+ Interest Received — Investing138.8—
Cash from Investing Activities-5.2—
Cash from Financing Activities
+ Proceeds from Issue of Shares13.1—
+ Proceeds from Borrowings7.6—
+ Payment of Lease Liabilities3.8—
+ Interest Paid2.6—
+ Dividends Paid0.3—
Cash from Financing Activities14.1—
Net Changes in Cash (pre-FX)-92.4—
Net Changes in Cash-92.4—
Reference Items
EBITDA43.150.1
EBITDA Margin %13.9613.64
Free Cash Flow (CFO − Capex)-102.6-102.6
Free Cash Flow per Basic Share-1.57-1.57
Cash Flow to Net Income-3.26—
Cash Paid for Taxes17.7—
Cash Paid for Interest2.6—
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.